See All Slides -

Slides

Presentation TCT 2015

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Sunil V. Rao, Giora Weisz

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

Presenter: Stephen G. Ellis, Lorenz Raber, Patrick W. Serruys

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman

October 13, 2015

Presentation TCT 2015

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Presentation TCT 2015

TCT 35: FFR Gray Zone and Clinical Outcome

Presenter: Javier Escaned, Johan HC Reiber, Julien Adjedj

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

Presentation TCT 2015

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Presenter: Eric Boersma, Richard Smalling, Pieter C. Smits

October 13, 2015

Advertisement

Slides

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

TCT 35: FFR Gray Zone and Clinical Outcome

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content